140 related articles for article (PubMed ID: 15831594)
1. Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.
Baser ME; Mautner VF; Parry DM; Evans DG
J Med Genet; 2005 Dec; 42(12):903-6. PubMed ID: 15831594
[TBL] [Abstract][Full Text] [Related]
2. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.
Baser ME; Makariou EV; Parry DM
J Neurosurg; 2002 Feb; 96(2):217-22. PubMed ID: 11838793
[TBL] [Abstract][Full Text] [Related]
3. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
[TBL] [Abstract][Full Text] [Related]
4. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
5. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
Evans DG; Ramsden RT; Gokhale C; Bowers N; Huson SM; Wallace A
Clin Genet; 2007 Apr; 71(4):354-8. PubMed ID: 17470137
[TBL] [Abstract][Full Text] [Related]
6. Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
Evans DG; Baser ME; O'Reilly B; Rowe J; Gleeson M; Saeed S; King A; Huson SM; Kerr R; Thomas N; Irving R; MacFarlane R; Ferner R; McLeod R; Moffat D; Ramsden R
Br J Neurosurg; 2005 Feb; 19(1):5-12. PubMed ID: 16147576
[TBL] [Abstract][Full Text] [Related]
7. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
Halum SL; Erbe CB; Friedland DR; Wackym PA
Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
[TBL] [Abstract][Full Text] [Related]
8. Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma development.
Woods R; Friedman JM; Evans DG; Baser ME; Joe H
Genet Epidemiol; 2003 May; 24(4):265-72. PubMed ID: 12687643
[TBL] [Abstract][Full Text] [Related]
9. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
10. Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.
Mahboubi H; Maducdoc MM; Yau AY; Ziai K; Ghavami Y; Badran KW; Al-Thobaiti M; Brandon B; Djalilian HR
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):822-31. PubMed ID: 25791708
[TBL] [Abstract][Full Text] [Related]
11. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
12. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology of vestibular schwannomas.
Chang LS; Welling DB
Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
[TBL] [Abstract][Full Text] [Related]
14. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
15. [Type 2 neurofibromatosis without acoustic neuroma].
Mautner VF; Lindenau M; Köppen J; Hazim W; Kluwe L
Zentralbl Neurochir; 1995; 56(2):83-7. PubMed ID: 7639047
[TBL] [Abstract][Full Text] [Related]
16. Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.
Picry A; Bonne NX; Ding J; Aboukais R; Lejeune JP; Baroncini M; Dubrulle F; Vincent C
Laryngoscope; 2016 Oct; 126(10):2358-62. PubMed ID: 27075822
[TBL] [Abstract][Full Text] [Related]
17. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.
Evans DG; Moran A; King A; Saeed S; Gurusinghe N; Ramsden R
Otol Neurotol; 2005 Jan; 26(1):93-7. PubMed ID: 15699726
[TBL] [Abstract][Full Text] [Related]
18. Linear accelerator radiosurgery for treatment of vestibular schwannomas in neurofibromatosis 2.
Kuo YH; Roos D; Brophy BP
J Clin Neurosci; 2008 Jul; 15(7):744-8. PubMed ID: 18403208
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
20. Growth of benign and malignant schwannoma xenografts in severe combined immunodeficiency mice.
Chang LS; Jacob A; Lorenz M; Rock J; Akhmametyeva EM; Mihai G; Schmalbrock P; Chaudhury AR; Lopez R; Yamate J; John MR; Wickert H; Neff BA; Dodson E; Welling DB
Laryngoscope; 2006 Nov; 116(11):2018-26. PubMed ID: 17075413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
